Innovative Widget Provides N.Y. Emergency Rooms With PEP Info
In New York, a new resource may help put an end to the confusion among emergency and general health care providers regarding HIV post-exposure prophyl...
HIV News & Views
Share:
Listens: 15
About
"HIV News & Views" is an ongoing podcast series from TheBody.com/TheBodyPRO.com in which we talk with HIV doctors, researchers, advocates and others, to get their takes on important HIV news.
Earlier HIV/AIDS Treatment Recommended in New Guidelines: Expert Summarizes
Looking for an expert summary of the latest revisions to the official U.S. HIV treatment guidelines? Check out this exclusive interview with David Woh...
Overweight People With HIV See Lower CD4 Gain While on HIV Medications, Study Suggests
Until the mid-1990s in the U.S., packing on a few extra pounds seemed like a good thing: It helped protect a person against the dangers of wasting and...
HIV/AIDS Activists Give Harsh Grades to Drug Companies
Abbott Laboratories: F. Hoffman-La Roche Ltd.: D. Boehringer Ingelheim: D+. If the nine major HIV drug companies were in school, most would probably b...
HIV and Swine Flu (H1N1): An Update on Intersecting Pandemics
We had a short break from the panic over swine flu (H1N1). But as this year's flu season approaches in the U.S. and the rest of the Northern Hemispher...
What Does H1N1 (Swine) Flu Mean for People With HIV/AIDS?
As a swine flu virus appears to make its way across the world, so has misinformation and confusion about what the virus is and what sort of threat it ...
Update to the U.S. DHHS Antiretroviral Treatment Guidelines for Adults and Adolescents
On Nov. 3, 2008, the U.S. government updated its Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. These guide...
HIV Expert Answers Common HIV Questions in New Book
Joel Gallant, M.D., M.P.H., is not only a widely respected HIV clinician and researcher: He's also an online HIV expert, spending some of his free tim...
What's so Great About TMC114?
TheBody.com interviewed Dr. Cal Cohen, one of the lead researchers who investigated TMC114 (darunavir, Prezista) in clinical trials, to get his take o...
A New Way to Fight HIV: CCR5 Inhibitors
The past year has brought so many new drug approvals that even some HIV experts are scratching their heads as they try to figure out how all of these ...